SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-022457
Filing Date
2018-08-29
Accepted
2018-08-29 16:10:59
Documents
5
Period of Report
2018-08-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-8k_20180827.htm 8-K 33732
2 EX-99.1 rare-ex991_6.htm EX-99.1 35623
3 EX-99.2 rare-ex992_7.htm EX-99.2 15244
4 GRAPHIC gfcniox55vim000001.jpg GRAPHIC 348834
5 GRAPHIC gfhrcwz1w0qk000001.jpg GRAPHIC 348834
  Complete submission text file 0001564590-18-022457.txt   1046358
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 181044439
SIC: 2834 Pharmaceutical Preparations